Safety and Pharmacokinetics Study of MBX 2109 in Adult Subjects With Normal and Impaired Renal Function

Description

Evaluate the Safety and Pharmacokinetics of MBX 2109 in Adult Subjects with Normal and Impaired Renal Function

Conditions

Renal Impairment

Talk to us

Study Overview

On this page

Study Details

Study overview

Evaluate the Safety and Pharmacokinetics of MBX 2109 in Adult Subjects with Normal and Impaired Renal Function

A Phase 1, Open-Label, Parallel-Group, Single Dose Adaptive Study to Evaluate the Safety and Pharmacokinetics of MBX 2109 in Adult Subjects With Normal and Impaired Renal Function

Safety and Pharmacokinetics Study of MBX 2109 in Adult Subjects With Normal and Impaired Renal Function

Condition
Renal Impairment
Intervention / Treatment

-

Contacts and Locations

Miami

MBX Biosciences Investigational Site, Miami, Florida, United States, 33136

Tampa

MBX Bioscience Investigational Site, Tampa, Florida, United States, 33603

Minneapolis

MBX Biosciences Investigational Site, Minneapolis, Minnesota, United States, 55101

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

    Ages Eligible for Study

    18 Years to 80 Years

    Sexes Eligible for Study

    ALL

    Accepts Healthy Volunteers

    Yes

    Collaborators and Investigators

    MBX Biosciences,

    Study Record Dates

    2024-10-12